Colinz Laboratories Limited (BOM:531210)
India flag India · Delayed Price · Currency is INR
48.51
+2.31 (5.00%)
At close: May 26, 2026

Colinz Laboratories Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
61.3665.2870.371.5569.74
Revenue Growth (YoY)
-6.00%-7.14%-1.75%2.59%13.24%
Cost of Revenue
17.121.4124.4623.9423.74
Gross Profit
44.2643.8745.8447.6146.01
Selling, General & Admin
26.9630.2731.3432.230.34
Other Operating Expenses
13.238.659.089.099.8
Operating Expenses
41.7540.2341.7242.5742.16
Operating Income
2.513.644.135.043.85
Interest Expense
-0.47-0.42-0.37-0.52-0.76
Interest & Investment Income
-2.882.741.71.67
Other Non Operating Income (Expenses)
4.840.10.010.020.04
EBT Excluding Unusual Items
6.896.196.56.244.8
Gain (Loss) on Sale of Assets
----0.24-
Pretax Income
6.896.196.564.8
Income Tax Expense
1.751.231.641.421.41
Net Income
5.154.974.874.573.39
Net Income to Common
5.154.974.874.573.39
Net Income Growth
3.60%2.03%6.41%34.81%63.44%
Shares Outstanding (Basic)
33335
Shares Outstanding (Diluted)
33335
Shares Change (YoY)
0.05%-0.04%0.34%-45.19%-0.61%
EPS (Basic)
2.041.971.931.820.74
EPS (Diluted)
2.041.971.931.820.74
EPS Growth
3.55%2.07%6.04%145.95%64.44%
Free Cash Flow
25.41-17.1610.354.034.3
Free Cash Flow Per Share
10.08-6.814.101.600.94
Gross Margin
72.13%67.21%65.21%66.54%65.97%
Operating Margin
4.09%5.58%5.87%7.04%5.52%
Profit Margin
8.38%7.61%6.92%6.39%4.87%
Free Cash Flow Margin
41.41%-26.28%14.72%5.63%6.16%
EBITDA
4.084.955.436.335.86
EBITDA Margin
6.64%7.58%7.72%8.84%8.40%
D&A For EBITDA
1.561.311.31.292.01
EBIT
2.513.644.135.043.85
EBIT Margin
4.09%5.58%5.87%7.04%5.52%
Effective Tax Rate
25.34%19.83%25.16%23.74%29.36%
Revenue as Reported
66.2168.2673.0573.2771.45
Advertising Expenses
-0.180.110.160.11
Source: S&P Global Market Intelligence. Standard template. Financial Sources.